Coupang Operating Cash Flow increased by 124.4% to $184.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 48.0%, from $354.00M to $184.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 44.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.88M | -$55.37M | -$203.17M | -$54.94M | -$18.26M | $58.16M | $580.04M | $501.00M | $820.00M | $722.00M | $609.00M | $212.00M | $664.00M | $334.00M | $676.00M | $354.00M | $545.00M | $792.00M | $82.00M | $184.00M |
| QoQ Change | — | -279.3% | -267.0% | +73.0% | +66.8% | +418.5% | +897.2% | -13.6% | +63.7% | -12.0% | -15.7% | -65.2% | +213.2% | -49.7% | +102.4% | -47.6% | +54.0% | +45.3% | -89.6% | +124.4% |
| YoY Change | — | — | — | — | -159.1% | +205.1% | +385.5% | >999% | >999% | >999% | +5.0% | -57.7% | -19.0% | -53.7% | +11.0% | +67.0% | -17.9% | +137.1% | -87.9% | -48.0% |